Solel Partners LP Portfolio
Auto-discovered 13F filer (Top-2000 by latest reported value).
SEC 13F CIK: 0001790604
What is a 13F filing? Who files one and when · What 13F filings can't tell you
Q4 2025 · 22 positions · Total reported value $618.24M · Top-10 concentration 70.4% · Updated 2026-10-18
Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR
Turnover: 64.0% · 6 new · 9 cut · 1 exited
Active Share (vs S&P 500): 95.3% · vs QQQ: 95.8% — share of the book that differs from index weights (higher = more active) · ranking
Est. Qtr Return (Q1 2026 → Q2 2026): +20.8% · vs SPY +6.0% · Prev Value $467.67M — last quarter positions weighted by this quarter price moves · ranking
In its Q4 2025 13F filing, Solel Partners LP disclosed 22 equity positions with a combined reported value of $618.24M. The filing implies a focused portfolio: its ten largest positions account for 70.4% of reported value. HoldingsHub classifies the profile as Small / Focused / High Turnover.
The largest disclosed positions as of Q4 2025 were UNH ($68.18M), SYF ($61.65M), CVS ($47.12M). By sector, the heaviest allocations are Consumer Discretionary 28.2%, Health Care 19.6%. Versus the prior quarter, allocation shifted toward Real Estate (+4.2pp), Technology (+2.9pp) and away from Health Care (-1.4pp), Consumer Discretionary (-1.7pp).
Versus the prior quarter, Solel Partners LP opened 6 new positions, trimmed 9 and fully exited 1, a turnover rate of 64.0% of positions. The portfolio's overlap with the prior quarter was 86% of names.
The largest new positions opened in Q4 2025 were DKNG ($40.65M), ESS ($20.07M), CALM ($14.46M).
Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.
New Positions (Q4 2025)
Fully Exited (vs previous quarter)
No tracked position was fully exited this quarter.
Insider Transactions (Form 4)
Latest Solel Partners LP buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.
No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.
Fund Profile
Solel Partners LP is an SEC-registered 13F filer based in Boston, MA, United States. As of Q2 2026 it reported 24 US equity positions with a combined value of $588.49M. HoldingsHub carries 12 quarters of its filings (Q3 2023–Q2 2026).
Firm Snapshot
- Headquarters: BOSTON, MA, United States
- SEC registration: 801-117394 (status: Approved), registered 2019-09-26
- Regulatory AUM (Form ADV): $1.24B as of 2026-03-24
- Client mix (by RAUM): pension and profit-sharing plans 100%
- Manages 1 private funds, of which 1 hedge funds
Portfolio Structure
- 24 positions · $588.49M reported value (Q2 2026)
- Top 10 holdings = 72.6% of reported value
- Largest position: HUM (HUMANA INC) at 11.0%
- Average position size: $24.52M
Sector Tilt
- Health Care 32.5%
- Consumer Discretionary 27.9%
- Financials 14.0%
- (classified holdings cover 100% of value)
Quarterly Activity
- Q2 2026: 6 new, 5 added, 9 reduced, 1 exited
- 4 positions unchanged
Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.
Sector Allocation
| # | Company | Shares | Value | Weight | Allocation | Change |
|---|---|---|---|---|---|---|
| 1 |
|
206.53K | $68.18M | 11.03% | Hold | |
| 2 |
|
739.00K | $61.65M | 9.97% | Hold | |
| 3 |
|
593.70K | $47.12M | 7.62% | Reduce | |
| 4 |
|
1.27M | $43.62M | 7.06% | Add | |
| 5 |
|
2.80M | $43.27M | 7.00% | Reduce | |
| 6 |
|
1.18M | $40.65M | 6.58% | New | |
| 7 |
|
552.62K | $38.98M | 6.30% | Reduce | |
| 8 |
|
285.50K | $31.43M | 5.08% | Add | |
| 9 |
|
87.00K | $31.07M | 5.03% | Hold | |
| 10 |
|
113.50K | $29.07M | 4.70% | Add | |
| 11 |
|
167.00K | $24.88M | 4.02% | Add | |
| 12 |
|
3.15M | $24.50M | 3.96% | Add | |
| 13 |
|
1.86M | $23.98M | 3.88% | Add | |
| 14 |
|
76.70K | $20.07M | 3.25% | New | |
| 15 |
|
307.70K | $18.91M | 3.06% | Reduce | |
| 16 |
|
693.85K | $16.23M | 2.62% | Reduce | |
| 17 |
|
181.70K | $14.46M | 2.34% | New | |
| 18 |
|
1.25M | $10.25M | 1.66% | Hold | |
| 19 |
|
266.59K | $8.30M | 1.34% | Hold | |
| 20 |
|
1.04M | $8.10M | 1.31% | Reduce | |
| 21 |
|
873.69K | $7.52M | 1.22% | Hold | |
| 22 |
|
4.58M | $6.00M | 0.97% | Hold | |
FAQ
What did Solel Partners LP buy in 2025-Q4?
In its 2025-Q4 13F filing, Solel Partners LP reported 22 equity positions worth $618.24M in aggregate; its largest disclosed positions were UNH ($68.18M), SYF ($61.65M), CVS ($47.12M).
How large is Solel Partners LP's portfolio?
Solel Partners LP reported $618.24M of long equity holdings across 22 positions as of 2025-Q4. Top-10 holdings account for 70.4% of reported value.
What is Solel Partners LP's investment style?
HoldingsHub classifies the portfolio as Small / Focused / High Turnover, computed from size, concentration, sector tilt and turnover.
Where does this data come from?
All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.